Concerns Regarding Amyloid Hypothesis in Alzheimer’s Disease Addressed at 7th Annual Meeting

WASHINGTON–(BUSINESS WIRE)–Continuing in their mission to promote advances in the development and use of CNS therapeutic agents, the International Society for CNS Clinical Trials and Methodology (ISCTM) met February 21, 2011 in Washington, D.C. to discuss one of the most important issues facing the field today.  (Full Release)